Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Petersenn

Showing results (11-20 of 123) with videos related to

Pageof 13
Sort By:
Pituitary|June 8, 2012
Medical management of Cushing's disease: what is the future?Maria Fleseriu, Stephan Petersenn
Pituitary|January 5, 2020
Diagnosis and management of prolactinomas: current challengesStephan Petersenn, Andrea Giustina
Pituitary|March 12, 2015
Cushing disease: where do we stand, where are we heading?Maria Fleseriu, Stephan Petersenn
Pituitary|January 7, 2015
Medical therapy for Cushing's disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockersMaria Fleseriu, Stephan Petersenn
Journal of Neuro-Oncology|May 16, 2013
New avenues in the medical treatment of Cushing's disease: corticotroph tumor targeted therapyMaria Fleseriu, Stephan Petersenn
Pituitary|January 29, 2015
Pituitary-directed medical therapy in Cushing's diseaseStephan Petersenn, Maria Fleseriu
Reviews in Endocrine & Metabolic Disorders|February 27, 2018
Neuroendocrine neoplasms - still a challenge despite major advances in clinical care with the development of specialized guidelinesStephan Petersenn, Christian A Koch
Reviews in Endocrine & Metabolic Disorders|February 9, 2018
Editorial : Neuroendocrine neoplasmsChristian A Koch, Stephan Petersenn
Clinical Endocrinology|January 31, 2009
GH treatment reduces total ghrelin in Prader-Willi syndrome (PWS) and may confound ghrelin studies in young PWS childrenBerthold P Hauffa, Stephan Petersenn
Reviews in Endocrine & Metabolic Disorders|May 17, 2020
Targeted systemic and peptide radio-ligand therapy for aggressive pituitary tumors and carcinomasStephan Petersenn, Anthony P Heaney
Pageof 13

Showing results (11-20 of 123) with videos related to

Sort By:
Pageof 13
Pituitary|June 8, 2012
Medical management of Cushing's disease: what is the future?Maria Fleseriu, Stephan Petersenn
Pituitary|January 5, 2020
Diagnosis and management of prolactinomas: current challengesStephan Petersenn, Andrea Giustina
Pituitary|March 12, 2015
Cushing disease: where do we stand, where are we heading?Maria Fleseriu, Stephan Petersenn
Pituitary|January 7, 2015
Medical therapy for Cushing's disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockersMaria Fleseriu, Stephan Petersenn
Journal of Neuro-Oncology|May 16, 2013
New avenues in the medical treatment of Cushing's disease: corticotroph tumor targeted therapyMaria Fleseriu, Stephan Petersenn
Pituitary|January 29, 2015
Pituitary-directed medical therapy in Cushing's diseaseStephan Petersenn, Maria Fleseriu
Reviews in Endocrine & Metabolic Disorders|February 27, 2018
Neuroendocrine neoplasms - still a challenge despite major advances in clinical care with the development of specialized guidelinesStephan Petersenn, Christian A Koch
Reviews in Endocrine & Metabolic Disorders|February 9, 2018
Editorial : Neuroendocrine neoplasmsChristian A Koch, Stephan Petersenn
Clinical Endocrinology|January 31, 2009
GH treatment reduces total ghrelin in Prader-Willi syndrome (PWS) and may confound ghrelin studies in young PWS childrenBerthold P Hauffa, Stephan Petersenn
Reviews in Endocrine & Metabolic Disorders|May 17, 2020
Targeted systemic and peptide radio-ligand therapy for aggressive pituitary tumors and carcinomasStephan Petersenn, Anthony P Heaney
Pageof 13